704 related articles for article (PubMed ID: 15939815)
1. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
4. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
[TBL] [Abstract][Full Text] [Related]
7. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
8. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
9. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Kishimoto I; Yamahara K; Osaki T; Minamino N; Horio T; Sawai K; Kawano Y; Miyazato M; Sata M; Kohno M; Nakao K; Kangawa K
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1516-21. PubMed ID: 19628785
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
Kirchhof P; Fabritz L; Kilić A; Begrow F; Breithardt G; Kuhn M
J Mol Cell Cardiol; 2004 May; 36(5):691-700. PubMed ID: 15135664
[TBL] [Abstract][Full Text] [Related]
12. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
14. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
17. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
18. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
[TBL] [Abstract][Full Text] [Related]
19. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
20. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
Christoffersen C; Bartels ED; Nielsen LB
Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
